Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression.
Ontology highlight
ABSTRACT: Rationale: Although stapled peptides offer a powerful solution to overcome the susceptibility of linear peptides to proteolytic degradation and improve their ability to cross membranes, an efficient and durable disease treatment strategy has not yet been developed due to the inevitable elimination of peptide inhibitors and rapid accumulation of target proteins. Methods: Herein we developed stapled peptide-based proteolysis-targeting chimeras (SP-PROTACs), that simultaneously exhibited improved cellular uptake and proteolytic stability attributed to the stapled peptides, and efficient target protein degradation promoted by the PROTACs. Based on the PMI peptide with dual specificity for both MDM2 and MDMX, a series of SP-PROTACs were designed. Results: Among them, the op
SUBMITTER: Chen S
PROVIDER: S-EPMC9516243 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA